Uterine Fibroid Drugs Market Set to Reach US$ 12.8 Billion by 2035 | Astute Analytica [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Companies including Kissei, Theramex, Sumitomo, and AbbVie drive progress through 2025 approvals, launches, and licensing deals. Chicago, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The global uterine fibroid drugs market was valued at US$ 3.8 billion in 2025 and is expected to reach US$ 12.8 billion by 2035, growing at a CAGR of 14.4% during the forecast period 2026–2035. Innovation within the uterine fibroid drugs market is currently defined by a robust pipeline of clinical trials aimed at refining patient eligibility and treatment personalization. For instance, researchers at UCSF are actively recruiting participants aged 21 to 53 in 2025 for the PLUM Study to strictly evaluate Letrozole efficacy. Concurrently, the TRUST study is targeting a specific demographic of women with fibroids less than 10 cm in diameter who are over 18 years old. These trials signify a major pivot toward precision medicine, moving away from broad-spectrum hormonal suppression. Kissei Pharmaceutical initiated a c
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- ?????????????????????????????????????????????8.23%???????(CAGR)????2033????2?2050?????????????????? [CNET News]CNET News
- Researchers identify immune trigger behind myocarditis after Covid vaccination [Los Angeles Times (CA)]Los Angeles Times
- Global Gene Therapy Market to Surge to USD 36.55 Billion by 2032 | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Pfizer (NYSE:PFE) had its price target lowered by analysts at Bank of America Corporation from $29.00 to $28.00. They now have a "neutral" rating on the stock.MarketBeat
- Pfizer declares $0.43 dividend [Seeking Alpha]Seeking Alpha
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 12/2/25 - Form 4
- 11/21/25 - Form 8-K
- 11/20/25 - Form 424B5
- PFE's page on the SEC website